找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Hodgkin Lymphoma; A Comprehensive Over Andreas Engert,Anas Younes Book 20152nd edition Springer International Publishing 2015 CD30.Combined

[复制链接]
楼主: controllers
发表于 2025-3-25 06:37:15 | 显示全部楼层
Andreas Engert,Anas YounesEvaluates new treatment options for both first-line and relapsed disease.Offers clear guidance on management of special patient groups and Hodgkin survivors.Discusses pathogenesis, clinical evaluation
发表于 2025-3-25 09:40:43 | 显示全部楼层
Hematologic Malignancieshttp://image.papertrans.cn/h/image/427831.jpg
发表于 2025-3-25 12:45:18 | 显示全部楼层
Prognostic Factors studies of patients treated with different treatment modalities. Survival curves according to Ann Arbor stage for more than 8,000 patients from the United States National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) programme are shown in Fig. 8.1.
发表于 2025-3-25 16:35:06 | 显示全部楼层
Principles of Radiation Therapy for Hodgkin Lymphomamotherapy. As the role of RT has transformed over the years from a single modality into a component of combined-modality therapy, the classic principles of RT fields, dose, and technique have fundamentally changed.
发表于 2025-3-25 23:57:52 | 显示全部楼层
发表于 2025-3-26 00:38:25 | 显示全部楼层
Principles of Chemotherapy in Hodgkin Lymphomaion. Patients with advanced disease represent a minority of those affected by Hodgkin lymphoma. However, these patients represent the group in which the development and effects of chemotherapy are most readily appreciated, since the role of radiation therapy is markedly less than in those with localized disease.
发表于 2025-3-26 06:51:39 | 显示全部楼层
The Management of Older Patients with Hodgkin Lymphomaar benefit for older patients, especially for advanced-stage disease. Survival rates for HL patients aged ≥60 years are significantly and disproportionately inferior compared with younger patient populations.
发表于 2025-3-26 09:38:54 | 显示全部楼层
Functional Imaging in Hodgkin Lymphomaa) a high chemo- and radiosensitivity of the tumour, (b) an increasing accuracy of staging procedures, and (c) different treatment strategies tailored to well-defined categories of patients with a different risk of treatment failure.
发表于 2025-3-26 14:48:26 | 显示全部楼层
发表于 2025-3-26 17:40:40 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-12 17:15
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表